Drugs Made In America Acquisition (DMII) Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Current Assets of $26037.0 for Q4 2025, down 56.32% year-over-year from $59615.0 in Q4 2024, and down 97.1% on a QoQ basis from $896356.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) has 2 years of Current Assets data on file, last reported at $26037.0 in Q4 2025.
- Quarterly Current Assets fell 56.32% year-over-year to $26037.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26037.0 (down 56.32% YoY) and the FY2025 annual result came in at $26037.0, down 56.32% from the prior year.
- Current Assets declined to $26037.0 in Q4 2025 per DMII's latest filing, from $896356.0 in the prior quarter.
- Across five years, Current Assets topped out at $896356.0 in Q3 2025 and bottomed at $26037.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 1.58 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 405,162.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 54,530.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 280,749.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 214,543.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 595,733.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 665,298.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 509,350.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 888,171.00 |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | 26,037.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,037.00 |
| Sep 30, 2025 | 896,356.00 |
| Dec 31, 2024 | 59,615.00 |